LUPINLupin Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹2,478.70
▲ 1.45%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,12,900.40
P/E21.21
P/B5.03
PEG0.24
ROE %26.91
ROCE %50.50
Debt / Equity0.29
EPS116.40
Revenue Growth %31.90
Profit Growth %89.00
Dividend Yield %0.48
Promoter Holding %47.02
FII Holding %34.73
DII Holding %—
Beta0.18
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 75% | ₹2,478.70 | ₹2,424.00 | ₹2,581.60 | 1.88 |
BUYConviction 87%
Why buy
- • Revenue growth: 31.9% YoY
- • Profit growth: 89.0% YoY
- • ROE: 26.9%
- • RSI: 60
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 75%)
Bull case
- • Revenue growth: 31.9% YoY
- • Profit growth: 89.0% YoY
- • ROE: 26.9%
- • RSI: 60
Bear case
- • Dividend yield: 0.48%
- • MACD: bearish
- • Volume: 0.7x 20-day average
- • Volume trend: 0.7x baseline
Key risks
- • Dividend yield: 0.48%
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹2,478.70
Stop Loss
₹2,357.42
risk 4.9%
Target 1 (1.5R)
₹2,660.62
+7.3%
Target 2 (3R)
₹2,842.53
+14.7%
Support (20d)
₹2,336.90
Resistance (52w)
₹2,526.90
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹121.28/share
ATR (volatility)
₹48.51
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹48.51). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
93
Technical
70
Momentum
72
Risk (safety)
86